School of Physical Education and Sport - Laboratory of Applied Nutrition and Metabolism, University of Sao Paulo, Av Mello de Moraes, 65, Sao Paulo, SP 05508-030, Brazil.
J Int Soc Sports Nutr. 2013 May 16;10(1):26. doi: 10.1186/1550-2783-10-26.
The aim of this study was to determine the effects of creatine supplementation on kidney function in resistance-trained individuals ingesting a high-protein diet.
A randomized, double-blind, placebo-controlled trial was performed. The participants were randomly allocated to receive either creatine (20 g/d for 5 d followed by 5 g/d throughout the trial) or placebo for 12 weeks. All of the participants were engaged in resistance training and consumed a high-protein diet (i.e., ≥ 1.2 g/Kg/d). Subjects were assessed at baseline (Pre) and after 12 weeks (Post). Glomerular filtration rate was measured by 51Cr-EDTA clearance. Additionally, blood samples and a 24-h urine collection were obtained for other kidney function assessments.
No significant differences were observed for 51Cr-EDTA clearance throughout the trial (Creatine: Pre 101.42 ± 13.11, Post 108.78 ± 14.41 mL/min/1.73m2; Placebo: Pre 103.29 ± 17.64, Post 106.68 ± 16.05 mL/min/1.73m2; group x time interaction: F = 0.21, p = 0.64). Creatinine clearance, serum and urinary urea, electrolytes, proteinuria, and albuminuria remained virtually unchanged.
A 12-week creatine supplementation protocol did not affect kidney function in resistance-trained healthy individuals consuming a high-protein diet; thus reinforcing the safety of this dietary supplement.
ClinicalTrials.gov NCT01817673.
本研究旨在确定在摄入高蛋白饮食的抗阻训练个体中,肌酸补充对肾功能的影响。
进行了一项随机、双盲、安慰剂对照试验。参与者被随机分配接受肌酸(5 天 20g/d,随后整个试验期间每天 5g/d)或安慰剂治疗 12 周。所有参与者都进行抗阻训练并摄入高蛋白饮食(即≥1.2g/Kg/d)。在基线(Pre)和 12 周后(Post)对受试者进行评估。肾小球滤过率通过 51Cr-EDTA 清除率测量。此外,还采集血样和 24 小时尿液进行其他肾功能评估。
整个试验过程中,51Cr-EDTA 清除率无显著差异(肌酸:Pre 101.42±13.11,Post 108.78±14.41mL/min/1.73m2;安慰剂:Pre 103.29±17.64,Post 106.68±16.05mL/min/1.73m2;组间时间交互作用:F=0.21,p=0.64)。肌酐清除率、血清和尿液尿素、电解质、蛋白尿和白蛋白尿几乎没有变化。
12 周肌酸补充方案不会影响摄入高蛋白饮食的抗阻训练健康个体的肾功能;从而强化了这种膳食补充剂的安全性。
ClinicalTrials.gov NCT01817673。